FDA inspection reveals critical supply chain vulnerabilities
Amanda Murphy, Senior Director at GlobalData, discusses how real-time intelligence can turns regulatory events into opportunities.
Regulation
EuropaBio calls for “bold approach to investment” amid EU Biotech Act
FDA’s revolving door reveals Pazdur as new CDER head
Japan’s MHLW grants orphan status to Kyowa and Orchard’s MLD therapy
FDA ‘green list’ flagging illegal GLP-1RA compounders is long overdue
Big pharma companies hit with FDA warning letters in drug ad clampdown
FDA chief blames decades of regulatory failure for misleading pharma ads
Five takeaway quotes from RFK Jr’s combative Senate hearing
